Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy

BACKGROUND: Bariatric surgery is known to decrease weight and the prevalence of comorbidities, but there is little evidence on the differential effect of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) on the remission of the aggregate outcome, metabolic syndrome, 4 years after surgery....

Descripción completa

Detalles Bibliográficos
Autores principales: Nassour, Ibrahim, Almandoz, Jaime P, Adams-Huet, Beverley, Kukreja, Sachin, Puzziferri, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614738/
https://www.ncbi.nlm.nih.gov/pubmed/29033596
http://dx.doi.org/10.2147/DMSO.S142731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614738/
https://www.ncbi.nlm.nih.gov/pubmed/29033596
http://dx.doi.org/10.2147/DMSO.S142731

Ejemplares similares